Cost-Effectiveness Analysis of Partner Notification Program for Human Immunodeficiency Virus Infection in Japan

Journal of Epidemiology

Volumn 8, Issue 2, 1998, Pages 123-128

  Rahman, Mahbubur ^a   Fukui, Tsuguya ^b   Asai, Atsushi ^a,b  

^a KYOTO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; CONTACT EXAMINATION; COST BENEFIT ANALYSIS; DISEASE TRANSMISSION; ECONOMICS; FEMALE; HEALTH CARE QUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; JAPAN; LIFE EXPECTANCY; MALE; SENSITIVITY AND SPECIFICITY; SEXUAL BEHAVIOR; SOCIOECONOMICS;

ADULT; AGE DISTRIBUTION; CONTACT TRACING; COST-BENEFIT ANALYSIS; FEMALE; HIV INFECTIONS; HUMANS; JAPAN; LIFE EXPECTANCY; MALE; PROGRAM EVALUATION; SENSITIVITY AND SPECIFICITY; SEXUAL BEHAVIOR; VALUE OF LIFE;

EID: 34547596949     PISSN: 09175040     EISSN: None     Source Type: Journal    
DOI: 10.2188/jea.8.123     Document Type: Article

References (37)

1. Toomy KE, Gates W Jr. Partner notification for the prevention of HIV infection. AIDS 1989; 3 (suppl 1):S57-S67.
2. Centers for Disease Control. Additional recommendations to reduce sexual and drug abuse-related transmission of human immunodeficiency T-lymphotropic virus type III/Iymphadenopathy-associated virus. MMWR 1986;35:152-155.
3. Centers for Disease Control. Public health service guidelines for counseling and antibody testing to prevent HIV infection and AIDS. MMWR 1987;36:509-515.
4. Potterat JJ, Spencer NE, Woodhouse DE, Muth JB. Partner notification in the control of human immunodeficiency virus infection. Am J Public Health 1989; 79:874-876.
5. Volberding PA, Lagakos SW, Koch MA, et al. Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD-4positive cells per cubic millimeter. N Engl JMedl990;323:941-949.
6. Adler MW, Johnson AM. Contact tracing for HIV infection. BMJ 1988;296:1420-21.
7. Rutherford GW, Woo JM. Contract tracing and the control of human immunodeficiency virus infection. JAMA 1988:259:3609-10.
8. Osborn JE. AIDS: politics and science. N Engl J Med 1988;318:444-47.
9. Ramstedt K, Hallhagen G, Lundin BI, et al. Contact tracing for human immunodeficiency virus (HIV) infection. SexTransmDis 1990;17:37-41.
10. Holtgrave DR, Valdiserri RO, Gerber AR, Hinman AR, Human immunodeficiency virus counseling, testing, referral, and partner notification services- A cost-benefit analysis. Arch Intern Med 1993;153:1225-1230.
11. Wykoff RF, Jones JL, Longshore ST, et al. Notification of the sex and needle-sharing partners of individuals with human immunodeficiency virus in rural South Carolina: 30 -month experience. Sex Transm Dis 1991;18(4):217-222.
12. Wykoff RF, Heath CW, Hollis SI, et al. Contact tracing to identify human immunodeficiency virus infection in a rural community. JAMA 1988;259:3563-3566.
13. Pattman RS, Gould ME. Partner notification for HIV infection in the United Kingdom : A look back on seven years experience in Newcastle Upon Tyne.Genitourin Med 1993;69:94-97.
14. Soda K, Ichikawa S, Fukutomi K, et al. Current situation of HIV/AIDS in Japan: in reports of the meeting of HIV surveillence committee. 2nd-6th March 1996, Yokohama.
15. Oya A. Potential for spread of HIV in Japan. Japanese Journal of Public Health 1993;39(4):193-195 (in Japanese).
16. Rahman M and Fukui T. Partner notification program and possibility of including it in the HIV prevention strategies in Japan. JEpidemiol 1996; 6(3): 158-165.
17. Matsuda J, Negeshi M, Minamitani M. et al. Relationship of HIV infected individuals with their partners, in : HIV epidemiology committee reports. MOHW. 1995: 365-373 (in Japanese).
18. Negeshi M. Research on case tracing from HIV infected individuals, in: Reports of the meeting of HIV surveillence committee March 1996:206-211, Yokohama, MOHW (in Japanese).
19. Weinstein MC.Graham JD, Siegel JE, Fineberg HV. Cost-effectiveness analysis of AIDS prevention programs: concept, complications, and illustrations. In: Turner CF, Miller HG, Moses LE, eds. AIDS : Sexual Behavior and Intravenous Drug Use. Washington, DC: National Academy press; 1989:471-499.
20. Munakata T, Tajima K. Japanese risk behaviors and their HIV/AIDS-preventive behaviors. AIDS Educ Prev. 1996 Apr;8(2):l 15-133.
21. Tajima K, and Soda K. Research activities of epidemiology in Japan-Epidemiology of AIDS/HIV in Japan. J Epidemiol 1996 ; 6(3 suppl):S67-S74.
22. Phair J, Munoz A, Detels R, et al. The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus typel. N Engl J Med, 1990;322:161-165.
23. McCarthy BD, Wong JB, Munoz A, Sonnenberg FA. Who should be screened for HIV? - A cost-effectiveness analysis. Arch Intern Med 1993;15:1107-1116.
24. The Life Tables. Statistics and Information Department. Minister's Secretariat. MOHW 1995.
25. National medical expenditures 1995. Statistical reports. MOHW (in Japanese).
26. Matsuyama Y, Takahashi S, Soda K. Study of medical cost of AIDS patients in Japan, In: HIV Epidemiology Committee Reports. MOHW. 1995:77-82.
27. Interpretation of scores. Institute of Social Insurance, Japan. 1997 (in Japanese).
28. Wald A. management of asymtomatic HIV infection. In:Libman H, Witzburg RA, eds. Clinical Manual for Care of the Adult Patient With HIV Infection. Boston, Mass: Dept. of Medicine, Boston City Hospital; 1990:233-244.
29. Kimura S, Oka S, Toyoshima T, et al. A randomized trial of reduced doses of azidothymidine in Japanese patients with human immunodeficiency virus type 1 infection. Intern Med 1992;31(7):871-876.
30. Rutherford GW, Woo JM, Neal DP, et al. partner notification and the control of human immunodeficiency virus infection: Two years of experience in San Francisco. Sex Transm Dis 1991;18(2):107-110.
31. Pavia AT, Benyo M, Niler L, Risk I. Partner notification for control of HIV: Results after 2 years of a statewide program in Utah. Am J Public Health 1993 ; 83:1418-1424.
32. Spencer NE, Hoffman RE, Raevsky BA, Wolf FC, Vernon TM. Partner notification for human immunodeficiency virus infection in Colorado: results across index case groups and costs. Int J STD & AIDS 1993 ;4:26-32.
33. Tsuji I, Fukao A, Shoji T, et al. Cost-effectiveness analysis of screening for colorectal cancer in Japan. Tohoku J ExpMed 1991; 164:269-278.
34. Tsuji I, Fukao A, Sugawara N, et al. Cost-effectiveness analysis of screening for gastric cancer in Japan. Tohoku J ExpMed 1991;164:279-284.
35. Rahman M, Tsutsui T, Kamae I, Takahasi T. Predicition of cost-effectiveness for human immunodeficiency (HIV) virus infection in Japan. J Epidemiol 1995;5(l):33-38.
36. Burke DS, Brunndage JF, Redfield RR, et al. Measurement of the false positive rate in a screening for human immunodeficiency virus infection. N Engl J Med 1988:319:961-964.
37. Centers for Disease Control. Partner notification for preventing human immunodeficiency virus(HIV) infection Colorado, Idaho, South Carolina, Virginia. MMWR 1988;37:393-96,401-402.